Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center

Santhosh Narayanan Department of Medicine, Government Medical College, Kozhikode, Kerala, India Background: Myelodysplastic syndrome (MDS), a disorder of clonal hematopoiesis, is an important clinical entity, but most of the studies available are conducted among the Western population. Its etiologic...

Full description

Bibliographic Details
Main Author: Narayanan S
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:Journal of Blood Medicine
Subjects:
Online Access:https://www.dovepress.com/clinical-hematological-and-cytogenetic-profile-of-adult-myelodysplasti-peer-reviewed-article-JBM
_version_ 1818335568375840768
author Narayanan S
author_facet Narayanan S
author_sort Narayanan S
collection DOAJ
description Santhosh Narayanan Department of Medicine, Government Medical College, Kozhikode, Kerala, India Background: Myelodysplastic syndrome (MDS), a disorder of clonal hematopoiesis, is an important clinical entity, but most of the studies available are conducted among the Western population. Its etiological factors and clinicohematological profile in the Indian population are quite diverse. The information regarding its prognostic factors and cytogenetics is very scarce.Objectives: (1) To assess the clinicohematological profile, cytogenetics, prognostic factors, and outcome of MDS and (2) to study its progression to acute myeloid leukemia (AML) in the selected patients over the study period.Methods: A prospective observational study was performed with patients from Department of Medicine and Hematology, Government Medical College, Kozhikode, who were diagnosed with MDS within the study period (from 1 January 2014 to 31 July 2015). Secondary causes of dysplasia were excluded. In possible cases, the international prognostic scoring system was followed. These patients were followed up for an additional 6 months to assess the progression of MDS to AML based on symptoms, signs, hemogram, or repeat peripheral smear/bone marrow studies.Results: Of the 60 patients, 73% were aged >60 years. Disease was common in males, with a male:female ratio of 7:3. Thirty-five percent of the patients were working in agricultural and allied fields and had pesticide exposure. Patients with prior radiation exposure had significant association with adverse outcome. Fatigue was the prominent symptom and was reported by 90% of the patients. Blasts were >5% in peripheral smear; bone marrow cytopenia and dysplasia at the time of diagnosis had significant association with risk of transforming to AML. Refractory anemia (RA), observed in 22 patients, was the most common type of MDS. Most of the patients with RA with excess blasts type-1 and RA with excess blasts type-2 transformed to AML, and the association was statistically significant. Deletion of short arm of fifth chromosome (5q deletion) was detected in 11 patients. All of them showed good response to treatment with lenalidomide and had a favorable outcome.Conclusion: This study highlights the various etiological factors, and the clinical profile of MDS seen in the Indian population. Cytogenetic analysis and application of the international prognostic scoring system has a significant bearing on the outcome, as exemplified by the response to lenalidomide in patients with 5q deletion. This study also indicates that proper diagnostic and prognostic assessment is necessary to institute appropriate therapeutic options. Keywords: MDS, cytogenetics, AML, prognosis
first_indexed 2024-12-13T14:25:30Z
format Article
id doaj.art-1f27a04e3d754d42adb30edd4004c499
institution Directory Open Access Journal
issn 1179-2736
language English
last_indexed 2024-12-13T14:25:30Z
publishDate 2017-02-01
publisher Dove Medical Press
record_format Article
series Journal of Blood Medicine
spelling doaj.art-1f27a04e3d754d42adb30edd4004c4992022-12-21T23:41:57ZengDove Medical PressJournal of Blood Medicine1179-27362017-02-01Volume 8212731526Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care centerNarayanan SSanthosh Narayanan Department of Medicine, Government Medical College, Kozhikode, Kerala, India Background: Myelodysplastic syndrome (MDS), a disorder of clonal hematopoiesis, is an important clinical entity, but most of the studies available are conducted among the Western population. Its etiological factors and clinicohematological profile in the Indian population are quite diverse. The information regarding its prognostic factors and cytogenetics is very scarce.Objectives: (1) To assess the clinicohematological profile, cytogenetics, prognostic factors, and outcome of MDS and (2) to study its progression to acute myeloid leukemia (AML) in the selected patients over the study period.Methods: A prospective observational study was performed with patients from Department of Medicine and Hematology, Government Medical College, Kozhikode, who were diagnosed with MDS within the study period (from 1 January 2014 to 31 July 2015). Secondary causes of dysplasia were excluded. In possible cases, the international prognostic scoring system was followed. These patients were followed up for an additional 6 months to assess the progression of MDS to AML based on symptoms, signs, hemogram, or repeat peripheral smear/bone marrow studies.Results: Of the 60 patients, 73% were aged >60 years. Disease was common in males, with a male:female ratio of 7:3. Thirty-five percent of the patients were working in agricultural and allied fields and had pesticide exposure. Patients with prior radiation exposure had significant association with adverse outcome. Fatigue was the prominent symptom and was reported by 90% of the patients. Blasts were >5% in peripheral smear; bone marrow cytopenia and dysplasia at the time of diagnosis had significant association with risk of transforming to AML. Refractory anemia (RA), observed in 22 patients, was the most common type of MDS. Most of the patients with RA with excess blasts type-1 and RA with excess blasts type-2 transformed to AML, and the association was statistically significant. Deletion of short arm of fifth chromosome (5q deletion) was detected in 11 patients. All of them showed good response to treatment with lenalidomide and had a favorable outcome.Conclusion: This study highlights the various etiological factors, and the clinical profile of MDS seen in the Indian population. Cytogenetic analysis and application of the international prognostic scoring system has a significant bearing on the outcome, as exemplified by the response to lenalidomide in patients with 5q deletion. This study also indicates that proper diagnostic and prognostic assessment is necessary to institute appropriate therapeutic options. Keywords: MDS, cytogenetics, AML, prognosishttps://www.dovepress.com/clinical-hematological-and-cytogenetic-profile-of-adult-myelodysplasti-peer-reviewed-article-JBMMDShaemotological profilecytogeneticsAML
spellingShingle Narayanan S
Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
Journal of Blood Medicine
MDS
haemotological profile
cytogenetics
AML
title Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
title_full Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
title_fullStr Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
title_full_unstemmed Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
title_short Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
title_sort clinical hematological and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
topic MDS
haemotological profile
cytogenetics
AML
url https://www.dovepress.com/clinical-hematological-and-cytogenetic-profile-of-adult-myelodysplasti-peer-reviewed-article-JBM
work_keys_str_mv AT narayanans clinicalhematologicalandcytogeneticprofileofadultmyelodysplasticsyndromeinatertiarycarecenter